Athens Medical Centre (STU:ACS) Moat Score: 0/10 (As of Jun. 25, 2026)


STU:ACS Athens Medical Centre SA STU:ACS
60 GF Score
Price €1.59
GF Value €1.93
! 8 Warning Signs
View Full Analysis

What is Athens Medical Centre Moat Score?

Athens Medical Centre has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Athens Medical Centre has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Athens Medical Centre might have No Moat - No discernible moat.

Athens Medical Centre  (STU:ACS) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Athens Medical Centre Moat Score Related Terms

STU:ACS
60GF Score
Athens Medical Centre SA STU:ACS
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Athens Medical Centre (STU:ACS) Overvalued in 2026?

Based on GuruFocus' analysis, Athens Medical Centre stock appears to be undervalued. The current stock price of €1.59 is trading 17.9% below its estimated GF Value™ of €1.93.

Key valuation signals for STU:ACS:

  • Moat Score: 0
  • GF Value™: €1.93 vs. price of €1.59 (17.9% below fair value)
  • GF Score™: 60/100 with 8 warning signs

No single metric tells the full story. See the STU:ACS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Athens Medical Centre Business Description

Other Exchanges IATR:GreeceACS:Germany
Address 5-7 Distomou Street Maroussi, Athens, GRC, 15125
Athens Medical Centre SA engages in the provision of healthcare services. It includes medical research and methods of treatment, training, and selection of executives and staff on behalf of the hospitals and importation of medical tools, instruments, machinery, and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. The company operates in Domestic healthcare service, Healthcare service provided abroad (Romania) and Sale of medical tools & sanitary/health equipment segment.
60GF Score

Get the complete analysis for STU:ACS

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.59
Price
€1.93
GF Value